Heart Failure

Heart Failure Society of America Joins ACC and AHA to Update Heart Failure Guidelines

Heart Failure Society of America Joins ACC and AHA to Update Heart Failure Guidelines

By

The American College of Cardiology, the American Heart Association, and the Heart Failure Society of America joined forces to update the previous 2013 heart failure treatment guidelines.

Newly Diagnosed Atrial Fibrillation Benefits From Rivaroxaban, Dabigatran

Newly Diagnosed Atrial Fibrillation Benefits From Rivaroxaban, Dabigatran

By

Direct oral anticoagulation reduced the risk of congestive heart failure admissions and all-cause mortality in both genders.

Parenteral Nutrition in Comorbid Congestive Heart Failure Outcomes

Parenteral Nutrition in Comorbid Congestive Heart Failure Outcomes

By

Patients with comorbid congestive heart failure who received parenteral nutrition experienced increased negative outcomes in their hospital stay.

HIV Infection's Impact on HF: Reduced EF vs Preserved EF in ART

HIV Infection's Impact on HF: Reduced EF vs Preserved EF in ART

By

HIV poses higher risks of heart failure even at younger ages of infection, and 25% of all new cases in the United States occur in people between age 13 and 24.

LVAD Improves Cardiac Function in Patients With Heart Failure

LVAD Improves Cardiac Function in Patients With Heart Failure

Following LVAD explantation, 38% of participants had heart function equivalent to a healthy man.

Long Term Effect of Ularitide in Acute HF on Cardiovascular Mortality

Long Term Effect of Ularitide in Acute HF on Cardiovascular Mortality

Patients in the ularitide group experienced reductions in systolic blood pressure and N-terminal pro-brain natriuretic peptide levels.

Cardiopulmonary Exercise Test: A Beneficial Prognostic Test

Cardiopulmonary Exercise Test: A Beneficial Prognostic Test

Cardiopulmonary exercise testing should be integrated with clinical, laboratory, and hemodynamic parameters.

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

By

Renin-angiotensin system inhibition was linked with a reduced 3-year risk of all-cause mortality in patients with congestive heart failure and atrial fibrillation.

Sacubitril/Valsartan Improves Glycemic Control in Comorbid Heart Failure and Diabetes

Sacubitril/Valsartan Improves Glycemic Control in Comorbid Heart Failure and Diabetes

By

HbA1c decreased by 0.16% in the enalapril group vs 0.26% in the sacubitril/valsartan group.

Should Defibrillator Be Added to Cardiac Resynchronization Therapy in Dilated Cardiomyopathy?

Should Defibrillator Be Added to Cardiac Resynchronization Therapy in Dilated Cardiomyopathy?

A greater benefit was noted among patients with defibrillator use in ischemic cardiomyopathy vs nonischemic cardiomyopathy.

High TSH, Free T4 Concentrations Associated With Heart Failure Severity

High TSH, Free T4 Concentrations Associated With Heart Failure Severity

By

Subclinical hypothyroidism with TSH has been linked to worse survival in patients with preexisting heart failure, according to research.

Heart Failure Risk Linked With Bone Mineral Density in Men

Heart Failure Risk Linked With Bone Mineral Density in Men

By

Total hip bone mineral density was associated with heart failure risk in black and non-black men, with an interaction by race.

Nonischemic Heart Failure Risk Increased With Rheumatoid Arthritis

Nonischemic Heart Failure Risk Increased With Rheumatoid Arthritis

By

Researchers noted that the relative risk of heart failure increased following a patient's RA diagnosis.

AHA Issues Science Advisory for Omega-3 Supplementation for CVD Prevention

AHA Issues Science Advisory for Omega-3 Supplementation for CVD Prevention

A review of 15 clinical trials tested the effects of omega-3 supplements on CV health.

Functional Status Decline Occurs at Least 2 Years Before Cardiovascular Events

Functional Status Decline Occurs at Least 2 Years Before Cardiovascular Events

By

A decline in function status occurred an average of 2 years before hospitalization for myocardial infarction, and 3 years before heart failure and stroke.

Nuanced Approach To Alcohol Consumption Key in Cardiovascular Disease Prevention

Nuanced Approach To Alcohol Consumption Key in Cardiovascular Disease Prevention

Researchers identified heterogeneous associations between levels of alcohol consumption and presentation of CVD.

Higher Hospital Admissions in Takotsubo Cardiomyopathy During Late Summer

Higher Hospital Admissions in Takotsubo Cardiomyopathy During Late Summer

By

Although more women are admitted with Takotsubo cardiomyopathy, more men ultimately die.

Addressing Competency Requirements in Heart Failure and Transplant Training Programs

Addressing Competency Requirements in Heart Failure and Transplant Training Programs

By

The Advanced Training Statement for advanced heart failure and transplant cardiology consists of 6 general competencies.

Cardiac MRI Critical in Diagnosing Takotsubo Cardiomyopathy

Cardiac MRI Critical in Diagnosing Takotsubo Cardiomyopathy

By

Cardiac MRI should be used to differentiate Takotsubo cardiomyopathy from similar conditions.

Heart Failure, Stroke Risk Increased With Cannabis Use

Heart Failure, Stroke Risk Increased With Cannabis Use

The investigators suggested that more research is needed to truly understand the pathophysiology behind cannabis' effect.

Zika Virus Impacts Cardiovascular Health

Zika Virus Impacts Cardiovascular Health

Patients infected with Zika virus developed arrhythmia or heart failure, according to researchers.

Diabetes Increases Risk of Adverse Outcomes in Heart Failure

Diabetes Increases Risk of Adverse Outcomes in Heart Failure

Researchers examined if diabetes status affected the 1-year all-cause and CVD mortality risk in patients with heart failure.

Affordable Care Act Repeal May Undo Reduced Heart Transplant Disparities

Affordable Care Act Repeal May Undo Reduced Heart Transplant Disparities

By

Heart transplant disparities have improved since the adoption of the Affordable Care Act; if the law is repealed, experts fear these disparities will return.

Broken Heart Syndrome: Q&A With D. Douglas Miller, MD

Broken Heart Syndrome: Q&A With D. Douglas Miller, MD

By

Learn about Takotsubo cardiomyopathy, more commonly known as broken heart syndrome, with D. Douglas Miller, MD.

Proton Pump Inhibitors Linked to Risk for Heart Failure, Death in CAD

Proton Pump Inhibitors Linked to Risk for Heart Failure, Death in CAD

By

The association between proton pump inhibitor use and incidence of heart failure and death was recently evaluated in a study.

Intensive Care Unit Overuse Common in Patients With Heart Disease

Intensive Care Unit Overuse Common in Patients With Heart Disease

Examination of over 1 million Medicare records found that the intensive care unit was overused for patients with heart and lung conditions.

Predictors of 30-Day Hospital Readmission in Heart Failure

Predictors of 30-Day Hospital Readmission in Heart Failure

While readmission may be necessary in some patients, researchers are urging the development of strategies to improve care transmission and reduce readmission rates.

Heart Failure, Atrial Fibrillation: Possible Markers for Mild Alzheimer's

Heart Failure, Atrial Fibrillation: Possible Markers for Mild Alzheimer's

By

Patients with both heart failure and atrial fibrillation had a pattern of milder Alzheimer's pathology.

Heart Failure Treatment Outcomes With CRT Vary by PR Interval

Heart Failure Treatment Outcomes With CRT Vary by PR Interval

Cardiac resynchronization therapy with defibrillation correlated with reduced hospitalization or all-cause mortality and all-cause mortality in advanced systolic heart failure.

Renin-Angiotensin System Inhibitors in Coronary Artery Disease Without Heart Failure

Renin-Angiotensin System Inhibitors in Coronary Artery Disease Without Heart Failure

By

Renin-angiotensin system inhibitors reduced cardiovascular events in patients with coronary artery disease when compared with placebo but not active controls.

Sign Up for Free e-Newsletters